TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation

被引:40
|
作者
Ma, Xiaoxiao [1 ]
Ma, Xiaomin [1 ]
Qiu, Yumin [1 ]
Zhu, Lihui [1 ]
Lin, Yueke [1 ]
You, Yajing [1 ]
Ma, Dapeng [1 ]
Qin, Zhenzhi [1 ]
Sun, Caiyu [1 ]
Zhao, Yunxue [2 ]
Sun, Yanlin [3 ]
Han, Lihui [1 ]
机构
[1] Shandong Univ, Sch Basic Med Sci, Dept Immunol, Shandong Prov Key Lab Infect & Immunol, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, Jinan 250012, Shandong, Peoples R China
[3] Shandong Univ, Sch Basic Med Sci, Dept Pathol, Jinan 250012, Shandong, Peoples R China
来源
CELL DEATH & DISEASE | 2018年 / 9卷
基金
中国国家自然科学基金;
关键词
HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; EXPRESSION; AUTOPHAGY; SURVIVAL;
D O I
10.1038/s41419-018-0644-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tripartite motif-containing 50 (TRIM50) belongs to the tripartite motif (TRIM) protein family, which has been implicated in the pathogenesis of multiple cancers. However, the role of TRIM50 in hepatocellular carcinoma (HCC) remains to be clarified. Here we showed that TRIM50 expression was significantly decreased in liver cancer tissues compared with corresponding non-cancerous liver tissues, and its decreased expression was significantly correlated with advanced disease progression. Gain-of-function assay by exogenous overexpression of TRIM50 in HCC cells showed that proliferation, colony formation, migration and invasion of HCC cells were significantly inhibited, whereas loss-of-function assay by TRIM50 knockdown showed that these malignant behaviors of HCC cells were significantly increased. Further investigation showed that TRIM50 could directly bind with SNAIL and induced K-48 linked polyubiquitous degradation of SNAIL protein, which further reversed SNAIL-mediated epithelial-to-mesenchymal transition (EMT) process of HCC cells. In vivo assay by xenograft tumor model verified the antitumor effect of TRIM50 on HCC. Taken together, these results showed that TRIM50 acted as a tumor suppressor in HCC cells by directly targeting SNAIL and reversing EMT, which further indicated that positive modulation of TRIM50 might be a novel therapeutic strategy for SNAIL overexpressed HCC cells.
引用
收藏
页数:11
相关论文
共 49 条
  • [41] RETRACTION: miR-140-5p Alleviates The Aggressive Progression Of Wilms' Tumor Through Directly Targeting TGFBR I Gene (Retraction of Vol 11, Pg 1641, 2019)
    Wang, H.
    Lou, C.
    Ma, N.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8605 - 8605
  • [42] MiR-192-5p-Modified Tumor-Associated Macrophages-Derived Exosome Suppressed Endometrial Cancer Progression Through Targeting IRAK1/NF-κB Signaling
    Wang, Yilin
    Ma, Hongsheng
    Li, Yajie
    Su, Rina
    REPRODUCTIVE SCIENCES, 2022, 29 (02) : 436 - 447
  • [43] MiR-192-5p-Modified Tumor-Associated Macrophages-Derived Exosome Suppressed Endometrial Cancer Progression Through Targeting IRAK1/NF-κB Signaling
    Yilin Wang
    Hongsheng Ma
    Yajie Li
    Rina Su
    Reproductive Sciences, 2022, 29 : 436 - 447
  • [44] MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition
    Xuan, Y-W
    Liao, M.
    Zhai, W-L
    Peng, L-J
    Tang, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (19) : 8411 - 8421
  • [45] C24-Ceramide Drives Gallbladder Cancer Progression Through Directly Targeting Phosphatidylinositol 5-Phosphate 4-Kinase Type-2 Gamma to Facilitate Mammalian Target of Rapamycin Signaling Activation
    Zhang, Yonglong
    Wang, Hui
    Chen, Tao
    Wang, Haolu
    Liang, Xiaowen
    Zhang, Yuchen
    Duan, Jinlin
    Qian, Shenjiao
    Qiao, Ke
    Zhang, Lei
    Liu, Yanfeng
    Wang, Jian
    HEPATOLOGY, 2021, 73 (02) : 692 - 712
  • [46] RETRACTED: MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition (Retracted Article)
    Sun, Xifeng
    Li, Kun
    Wang, Huiling
    Xia, Yifang
    Meng, Ping
    Leng, Xiaogang
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [47] Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation
    Xu, Hua
    Sun, Yin
    Huang, Chi-Ping
    You, Bosen
    Ye, Dingwei
    Chang, Chawnshang
    CANCERS, 2020, 12 (04)